FDA issues Final Guidance on use of “Potassium Salt” as an alternate name for Potassium Chloride

Hogan Lovells
Contact

Hogan Lovells

Last week the Food and Drug Administration (FDA) issued a Final Guidance document regarding the use of an alternate name for potassium chloride in food labeling.

The FDA’s Final Guidance states the agency will exercise enforcement discretion to allow the use of “potassium salt” as an alternative common or usual name for “potassium chloride.”1 The Final Guidance is a change from the FDA’s previous position in the draft guidance, which allowed for the alternate name “potassium chloride salt.” The agency received numerous comments from the food industry and non-governmental organizations requesting that FDA instead allow the name “potassium salt.” Many of these comments noted that food companies may be more likely to utilize potassium chloride if a more recognizable name for the ingredient may be used in the ingredient statement.

The FDA recognizes potassium chloride (KCl) can be used as a partial substitute for sodium chloride in food manufacturing, helping to reduce sodium content. The FDA’s final guidance confirms that the name “potassium salt” is unlikely to be misleading or to cause consumers to confuse the ingredient with sodium chloride. The agency explains the guidance is appropriate due in part to the important public health benefits that could result from reduced sodium and increased potassium intake.

We will continue to monitor developments related to FDA’s food labeling requirements. 

 

References

1 FDA, The Use of an Alternate Name for Potassium Chloride in Food Labeling: Guidance for Industry (Dec. 2020), https://www.fda.gov/media/125081/download.

[View source.]

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Hogan Lovells | Attorney Advertising

Written by:

Hogan Lovells
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

Hogan Lovells on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide